MoneyWorks4Me

Wockhardt informs about press release

16 Oct 2024 Evaluate
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed that it enclosed a Press Release titled ‘Wockhardt files fast-acting Insulin Aspart injection (ASPARAPIDTM) with DCGI; strengthens commitment to diabetes management’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1792.50
Dr. Reddys Labs. 1198.10
Cipla 1327.50
Lupin 2009.60
Zydus Lifesciences 1144.75
View more..